SKIM ranked #3 most innovative insights company in 2025
SKIM is named third most innovative insights company in Greenbook’s 2025 GRIT Business & Innovation Report, marking the third consecutive year.
When it comes to understanding what drives the decisions of physicians when they prescribe pharmaceuticals, conventional market research methods fall short. Often the measurement (physician interview) takes place long after the occurrence (patient consultation). The resulting time lapse leads to over-rationalization and generalization, missing the depth behind physicians’ prescribing decisions.
In this infographic, we show you the benefits of utilizing in-the-moment mobile research for physician-patient interaction.

Be the first to receive the latest market research insights, tips from industry peers and exclusive content to help you influence decision behavior.
SKIM is named third most innovative insights company in Greenbook’s 2025 GRIT Business & Innovation Report, marking the third consecutive year.
Stop guessing what consumers want. Use CrowdCraft to generate and validate product concepts, revealing what truly resonates at scale.
Learn how Bayer & SKIM forecast real-world adoption by combining conjoint analysis with sales data.
See how Air France-KLM used behavioral decision-making to capture real customer choices in complex booking journeys.